White matter predicts tDCS antidepressant effects in a sham-controlled clinical trial study
Author:
Funder
FAPESP
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00406-022-01504-7.pdf
Reference69 articles.
1. Murray CJL, Lopez AD (2017) Measuring global health: motivation and evolution of the global burden of disease study. Lancet 390:1460–1464
2. Stephan KE, Bach DR, Fletcher PC, Flint J, Frank MJ, Friston KJ et al (2016) Charting the landscape of priority problems in psychiatry, part 1: classification and diagnosis. Lancet Psychiatry 3:77–83
3. Kendrick T, Taylor D, Johnson CF (2019) Which first-line antidepressant? Br J Gen Pract 69:114–115
4. Brunoni AR, Valiengo L, Baccaro A, Zanão TA, de Oliveira JF, Goulart A et al (2013) The sertraline vs electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiat 70:383–391
5. Vittengl JR (2017) Poorer long-term outcomes among persons with major depressive disorder treated with medication. Psychother Psychosom 86:302–304
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3